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D15S63 is one of the loci, on chromosome 15q11-q13, that exhibit parent-of-origin dependent methylation
and that is commonly used in the diagnosis of Prader-Willi or Angelman syndromes (PWS/AS). A 28-kb deletion
spanning the D15S63 locus was identified in five unrelated patients; in each of them the deletion was inherited
from a normal parent. Three of the five families segregating the deletion were reported to be of Jewish Ashkenazi
ancestry, and in the other two families the ancestral origin was unknown. To determine whether the 28-kb
deletion is a benign variant, we screened for the deletion in 137 unselected Ashkenazi individuals and in 268
patients who were referred for molecular diagnosis of PWS/AS, of whom 89 were Ashkenazi and 47 were of
mixed origin (Ashkenazi and non-Ashkenazi Jews). In the control group, three individuals were carriers of
the deletion; among the patients, three were carriers, all of whom were Ashkenazi Jews. There was no significant
difference between the control group and the Ashkenazi patients, indicating that the deletion is not a cause
of PWS- and AS-like syndromes. The frequency of the 28-kb deletion in the Ashkenazi population was 1/75.
Since methylation analysis at the D15S63 locus may lead to misdiagnosis, we suggest the use of SNRPN, either
in a PCR-based assay or as a probe in Southern hybridization, as the method of choice in the diagnosis of
PWS/AS.
Prader-Willi syndrome (PWS [MIM 176270]) and An-
gelman syndrome (AS [MIM 105830]) are caused by
a deficiency of imprinted gene expression in, respec-
tively, the paternally and maternally inherited chro-
mosome 15q11-q13 (Nicholls et al. 1998). The clin-
ical diagnosis of these two syndromes is based on
differential methylation in the PWS/AS region; cur-
rently, the two loci that are used for the methylation
assay are the SNRPN gene and the D15S63 locus
(American Society of Human Genetics/American Col-
lege of Medical Genetics Test and Technology Trans-
fer Committee 1996). The methylation status at the
D15S63 locus is analyzed by Southern hybridization
using methylation-sensitive restriction enzymes and
hybridization with the PW71B probe (Dittrich et al.
1992). Recently, a 28-kb deletion spanning D15S63
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was detected, which led to misdiagnosis of either PWS
or AS (Buiting et al. 1999). The deletion was identified
in five unrelated patients, three of whom were re-
ported to be of Ashkenazi Jewish ancestry; the chro-
mosomes bearing the deletion had common alleles,
suggesting a founder mutation. Among 1,000 unre-
lated German individuals the deletion was not de-
tected. We further investigated the 28-kb deletion to
determine whether it is a benign polymorphism in the
Ashkenazi Jewish population or a mutation that has
a clinical effect on its carriers.
Two groups of individuals were analyzed: 137 un-
related and unselected healthy individuals of Ashke-
nazi origin (a control group) and a group of 268 pa-
tients referred for molecular diagnosis of either PWS
or AS in whom the clinical diagnosis could not be
confirmed. The origin of the patients is described in
table 1.
The 28-kb deletion was analyzed in the control
group by PCR-based assay (Buiting et al. 1999). Three
of the 274 alleles in the control group had the 28-kb
deletion; the deletion was confirmed by Southern hy-
bridization using CfoIBglII and PW71B as probes
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Table 1
Ethnic Origin of the Patients and the 28-kb Deletion
ORIGIN
NO. OF
Individuals Alleles
Deletion
Alleles
Control group:
Ashkenazi individuals 137 274 3
Patients:
Ashkenazi Jews 89 17847p225 3
Jews of mixed origin (Ashkenazi and non-Ashkenazi) 47 0
Sephardic/Oriental Jews 62 12447p171 0
Jews of unknown origin 40 80 0
Arabs 30 60 0
Total 268 536 3
(Lerer et al. 1994). In the three individuals the de-
letion was on the paternally derived chromosomes.
In the patient group, the methylation analysis was
performed, by Southern hybridization (CfoIBglII/
PW71B), as part of the molecular diagnosis. Among
the patients, 3 of the 225 alleles of Ashkenazi origin
had the 28-kb deletion; two patients, one each from
families 63 and 221, have been described elsewhere
(Buiting et al. 1999). In two patients the deletion was
on the paternally derived chromosomes, and in one it
was on the maternally derived chromosome. In all
three patients the methylation status of the SNRPN
was normal (Buiting et al. 1999). None of the non-
Ashkenazi Jewish patients (171 alleles) or the Arab
patients (60 alleles) had the 28-kb deletion.
The frequency of the 28-kb deletion mutation was
1.1% in the control group of Ashkenazi Jews and
1.3% in the patients of Ashkenazi origin; the differ-
ence between these samples is not statistically signif-
icant ( ; ). It is therefore suggested2x p 0.059 Pp .81
that the deletion is a benign variant and is not a cause
of syndromes such as PWS and AS. In both the patient
group and the control group, the frequency of the 28-
kb deletion variant in the Ashkenazi population was
1/75 (.0133 [95% confidence interval .0061–.0289]).
In the non-Ashkenazi Jewish population, if the dele-
tion exists, its frequency is much lower. As already
mentioned by Buiting et al. (1999), this polymorphism
is a pitfall in the diagnosis of PWS and AS and, if the
methylation assay using the PW71B probe is consid-
ered, a positive diagnosis should be confirmed by al-
ternative methods (Abeliovich 2000), especially in
Ashkenazi Jewish patients. This observation illus-
trates the advantage of the differential methylation
assay at the SNRPN gene, since it is not affected by
the polymorphic deletion of 28 kb. It is therefore rec-
ommended that the method of choice in the diagno-
sis of PWS/AS be based on SNRPN, in either a South-
ern hybridization (Glenn et al. 1996) or PCR-based
assay (Kosaki et al. 1997; Zeschnigk et al. 1997). The
SNRPN assay is also preferable for the analysis of
fetal tissues such as chorionic villi or amniocytes
(Glenn et al. 2000).
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